01-10-2002 | Original Article
Chemoimmunotherapy for melanoma with dacarbazine and 2,4-dinitrochlorobenzene elicits a specific T cell-dependent immune response
Published in: Cancer Immunology, Immunotherapy | Issue 8/2002
Login to get access01-10-2002 | Original Article
Published in: Cancer Immunology, Immunotherapy | Issue 8/2002
Login to get access